Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Novel Oral Anticoagulants”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02353585
What this trial is testing

Novel Oral Anticoagulants in Stroke Patients

Who this might be right for
Ischemic StrokeIntracranial Hemorrhages
University Hospital, Basel, Switzerland 1,050
Not applicableNot Yet RecruitingNCT05764356
What this trial is testing

Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Who this might be right for
Novel Oral AnticoagulantsNOACsRivaroxaban+9 more
Peking University First Hospital 2,000
Not applicableStudy completedNCT04662515
What this trial is testing

NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications

Who this might be right for
Surgery, OralHemorrhagePostoperative Complications+3 more
Malmö University 216
Not applicableStudy completedNCT03292666
What this trial is testing

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

Who this might be right for
Venous ThromboembolismAnticoagulants and Bleeding Disorders
University of California, San Francisco 39,603
Not applicableUnknownNCT02906527
What this trial is testing

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)

Who this might be right for
Non Valvular Atrial Fibrillation (nv AF)
Assistance Publique - Hôpitaux de Paris 150,000
Large-scale testing (Phase 3)UnknownNCT01924325
What this trial is testing

Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events

Who this might be right for
Ischemic StrokeTIA
Xijing Hospital 10,000
Post-approval studies (Phase 4)Active Not RecruitingNCT03129555
What this trial is testing

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Herlev and Gentofte Hospital 5,000
Not applicableStudy completedNCT02478177
What this trial is testing

Addressing Real-world Anticoagulant Management Issues in Stroke

Who this might be right for
StrokeCerebrovascular StrokeIntracerebral Hemorrhage
Duke University 6,000
Not applicableStudy completedNCT04645537
What this trial is testing

Finnish AntiCoagulation in Atrial Fibrillation (FinACAF)

Who this might be right for
Atrial Fibrillation
Helsinki University Central Hospital 400,000
Not applicableUnknownNCT02623049
What this trial is testing

Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation and Flutter
Rabin Medical Center 150
Not applicableEnrolling By InvitationNCT07654634
What this trial is testing

Precision Antithrombotic Therapy

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)MI(Myocardial Infarction)+1 more
The Third Xiangya Hospital of Central South University 5,000
Not applicableNot Yet RecruitingNCT06864052
What this trial is testing

The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation

Who this might be right for
StrokeAtrial Fibrillation
Ewha Womans University Seoul Hospital 400
Large-scale testing (Phase 3)Study completedNCT03702582
What this trial is testing

Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation

Who this might be right for
Atrial FibrillationStrokeBleeding
Massachusetts General Hospital 100
Not applicableStudy completedNCT01704053
What this trial is testing

Effect of New Oral Anticoagulants Dabigatran and Rivaroxaban on Point of Care Coagulation Testing - an Ex-Vivo Study

Who this might be right for
Clot Formation and Platelet Aggregation in Point of Care Testing
Johann Wolfgang Goethe University Hospital 34
Post-approval studies (Phase 4)UnknownNCT01478282
What this trial is testing

Reversal of the Antithrombotic Action of New Oral Anticoagulants

Who this might be right for
ThrombosisAnticoagulant-induced BleedingAnticoagulant Overdosage+1 more
Gines Escolar 10
Not applicableWithdrawnNCT03537521
What this trial is testing

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots

Who this might be right for
Severe BleedingUrgent Surgery
Cardioangiologisches Centrum Bethanien
Not applicableStudy completedNCT05086991
What this trial is testing

AIHEMAF - P "An Innovative Healthcare Model for AF Patients"

Who this might be right for
Atrial Fibrillation
Farmacia La Regina s.r.l. 50
Not applicableUnknownNCT03670446
What this trial is testing

Pharmacists' Intervention in Patients Using Novel Oral Anticoagulants：A Study on Behavioral Patterns

Who this might be right for
AnticoagulantsIntentionBehavioral Symptoms
Cui Yimin 400
Large-scale testing (Phase 3)UnknownNCT02544932
What this trial is testing

Pleotropic Effect of New Oral Anticoagulants

Who this might be right for
Atrial Fibrillation
Kyunghee University Medical Center 55
Not applicableUnknownNCT04942873
What this trial is testing

The Adherence to Oral Anticoagulant in Chinese Patients With NVAF

Who this might be right for
Nonvalvular Atrial Fibrillation
Second Affiliated Hospital, Zhejiang University, School of Medicine 500
Next Page